Recent data from the Hong Kong Stock Exchange reveals that on May 19, DFZQ reduced its stake in CSPC PHARMA (01093) by 9.824 million shares. The transaction was executed at an average price of HK$7.4527 per share, amounting to a total value of approximately HK$73.2153 million. Following this disposal, DFZQ's latest shareholding stands at about 571 million shares, representing a 4.96% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.